Drugmaker Raises U.S. Price of Muscular-Dystrophy Treatment

PTC Therapeutics Inc. this month increased the list price of its muscular-dystrophy treatment by about 9%, to more than $65,000 annually for a common dosage.

from WSJ.com: US Business http://ift.tt/2FQKAZ0
via IFTTT